EcoDrugPlus

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSPNYG00000012532
Gene Symbol: PSENEN
3 Cross references
183 Possible Orthologues:

Presenilin-1-Like

Ensembl ID : ENSPNYG00000010399
Gene Symbol: LOC102207316
3 Cross references
200 Possible Orthologues:

Primary Amine Oxidase, Liver Isozyme-Like

Ensembl ID : ENSPNYG00000002283
Gene Symbol: LOC102195665
3 Cross references
404 Possible Orthologues:

Probable Histone Deacetylase 1-B

Ensembl ID : ENSPNYG00000004402
Gene Symbol: LOC102193309
3 Cross references
250 Possible Orthologues:

Probable Histone Deacetylase 1-B

Ensembl ID : ENSPNYG00000006049
Gene Symbol: LOC102207424
4 Cross references
255 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSPNYG00000008970
Gene Symbol: PGR
3 Cross references
193 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSPNYG00000016165
Gene Symbol: PTGDR2
2 Cross references
135 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSPNYG00000004941
Gene Symbol: PTGDR2
3 Cross references
145 Possible Orthologues:

Prostaglandin E Receptor 2a (Subtype Ep2)

Ensembl ID : ENSPNYG00000016772
Gene Symbol: PTGER2A
1 Cross references
202 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSPNYG00000021955
Gene Symbol: PTGER3
3 Cross references
194 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSPNYG00000003060
Gene Symbol: PTGER4
3 Cross references
201 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSPNYG00000006220
Gene Symbol: LOC102205258
3 Cross references
167 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).